NO20053762L - Kondensert furanforbindelse. - Google Patents

Kondensert furanforbindelse.

Info

Publication number: NO20053762L
Authority: NO; Norway
Prior art keywords: represents hydrogen; furan compound; compound; condensed furan; condensed
Prior art date: 2003-01-09

Application number

NO20053762A

Other languages

English (en)

Norwegian (no)

Other versions

NO20053762D0 (no

Inventor

Takayuki Kawaguchi

Jun Murakami

Hidenori Akatsuka

Toru Iijima

Takashi Mitsui

Tatsuya Watanabe

Original Assignee

Tanabe Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-09

Filing date

2005-08-08

Publication date

2005-10-07

2005-08-08 Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co

2005-08-08 Publication of NO20053762D0 publication Critical patent/NO20053762D0/no

2005-10-07 Publication of NO20053762L publication Critical patent/NO20053762L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Immunology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

NO20053762A 2003-01-09 2005-08-08 Kondensert furanforbindelse. NO20053762L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2003003536		2003-01-09
JP2003334598A JP2005104838A (ja)	2003-01-09	2003-09-26	縮合フラン化合物
PCT/JP2004/000074 WO2004063202A1 (ja)	2003-01-09	2004-01-08	縮合フラン化合物

Publications (2)

Publication Number	Publication Date
NO20053762D0 NO20053762D0 (no)	2005-08-08
NO20053762L true NO20053762L (no)	2005-10-07

Family

ID=32716377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053762A NO20053762L (no)	2003-01-09	2005-08-08	Kondensert furanforbindelse.

Country Status (19)

Country	Link
US (2)	US7514449B2 (ja)
EP (1)	EP1582521A4 (ja)
JP (2)	JP2005104838A (ja)
KR (2)	KR20070094818A (ja)
CN (1)	CN100344632C (ja)
AR (1)	AR042827A1 (ja)
AU (1)	AU2004204003B2 (ja)
BR (1)	BRPI0406721A (ja)
CA (1)	CA2510519C (ja)
IL (1)	IL169193A0 (ja)
MX (1)	MXPA05007408A (ja)
MY (1)	MY139461A (ja)
NO (1)	NO20053762L (ja)
NZ (1)	NZ541198A (ja)
PL (1)	PL378249A1 (ja)
RU (1)	RU2302422C2 (ja)
TW (1)	TWI328588B (ja)
WO (1)	WO2004063202A1 (ja)
ZA (1)	ZA200504972B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI312345B (en) *	2003-06-30	2009-07-21	Mitsubishi Tanabe Pharma Corp	Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives
TW200524915A (en)	2003-09-26	2005-08-01	Tanabe Seiyaku Co	Carbamoyl-type benzofuran derivatives
TW200512181A (en) *	2003-09-26	2005-04-01	Tanabe Seiyaku Co	Amide-type carboxamide derivatives
JP4710445B2 (ja) *	2004-07-08	2011-06-29	田辺三菱製薬株式会社	医薬組成物
EP1630163A1 (de) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006083003A1 (ja) *	2005-02-02	2006-08-10	Ajinomoto Co., Inc.	新規ベンズアミジン化合物
JP2006298909A (ja) *	2005-03-25	2006-11-02	Tanabe Seiyaku Co Ltd	医薬組成物
WO2006137350A1 (ja) *	2005-06-22	2006-12-28	Kissei Pharmaceutical Co., Ltd.	新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
CN101305010A (zh) *	2005-09-01	2008-11-12	阿雷生物药品公司	Raf抑制剂化合物及其用法
CN100376582C (zh) *	2006-04-26	2008-03-26	浙江大学	一种六氢呋喃[3,2-c]喹啉衍生物的制备方法
CA2660546A1 (en) *	2006-08-21	2008-02-28	Genentech, Inc.	Aza-benzofuranyl compounds and methods of use
RU2448111C2 (ru) *	2006-08-21	2012-04-20	Дженентек, Инк.	Соединения азабензофуранила и способ их применения
AU2007286807B2 (en)	2006-08-21	2013-03-21	Genentech, Inc.	Aza-benzothiophenyl compounds and methods of use
JPWO2008108309A1 (ja) *	2007-03-02	2010-06-17	協和発酵キリン株式会社	縮環ピリジン誘導体
WO2010010469A2 (en) *	2008-07-25	2010-01-28	Abbott Gmbh & Co. Kg	Abeta (x-38..43) oligomers, and processes, compositions, and uses thereof
RU2396267C1 (ru) *	2009-03-03	2010-08-10	Южный научный центр Российской академии наук (ЮНЦ РАН)	4-ЗАМЕЩЕННЫЕ-3-(1-АЛКИЛ-2-ХЛОР-1Н-ИНДОЛ-3-ИЛ)ФУРАН-2,5-ДИОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ ДЛЯ ФОТОХИМИЧЕСКОГО ГЕНЕРИРОВАНИЯ СТАБИЛЬНЫХ ФЛУОРЕСЦИРУЮЩИХ СОЕДИНЕНИЙ И (4,5-ЗАМЕЩЕННЫЕ-6-АЛКИЛ-1Н-ФУРО[3,4-c]КАРБАЗОЛ-1,3(6Н)-ДИОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ФЛУОРОФОРОВ
CN102675230A (zh) *	2012-05-17	2012-09-19	盛世泰科生物医药技术(苏州)有限公司	一种3-氨基-2-氰基-6-溴吡嗪的制备方法
EP3323821A1 (en) *	2012-11-08	2018-05-23	Pfizer Inc	Heteroaromatic compounds and their use as dopamine d1 ligands
US9933880B2 (en) *	2014-03-17	2018-04-03	Tactual Labs Co.	Orthogonal signaling touch user, hand and object discrimination systems and methods
WO2016073493A2 (en) *	2014-11-03	2016-05-12	Thromboltyics, Llc	Antifibrinolytic compounds
TW201733985A (zh) *	2016-02-29	2017-10-01	陶氏農業科學公司	用於製備4-烷氧基-3-羥基吡啶甲酸之方法
CA3080695A1 (en)	2017-11-03	2019-05-09	Universite De Montreal	Compounds and use thereof in the expansion of stem cells and/or progenitor cells
HU231206B1 (hu)	2017-12-15	2021-10-28	Richter Gedeon Nyrt.	Triazolobenzazepinek
TW201938171A (zh)	2017-12-15	2019-10-01	匈牙利商羅特格登公司	作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
CN115747298B (zh) *	2022-10-10	2023-10-27	浙江大学	昆虫烟酰胺酶抑制剂及鉴定方法及用于杀虫剂的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU926914A1 (ru) *	1980-05-26	1992-04-23	Научно-исследовательский институт фармакологии АМН СССР	Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
JPS61218589A (ja) *	1985-03-26	1986-09-29	Eisai Co Ltd	５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
AU5883794A (en)	1993-01-20	1994-08-15	A. Menarini Industrie Farmaceutiche Riunite S.R.L.	Diazepin derivatives and antiviral compositions
KR960703856A (ko) *	1994-06-06	1996-08-31	가와노 다케히코	축합 고리를 갖는 카르복실산 화합물, 이의 염 및 이의 약학적 용도(novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof)
US5597823A (en)	1995-01-27	1997-01-28	Abbott Laboratories	Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
FR2761072B1 (fr) *	1997-03-20	1999-04-23	Synthelabo	Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
GB9711126D0 (en) *	1997-05-29	1997-07-23	Leo Pharm Prod Ltd	Cyanoamidines
EP0937711A1 (de)	1998-02-18	1999-08-25	Roche Diagnostics GmbH	Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
WO2001083456A1 (en) *	2000-04-27	2001-11-08	Yamanouchi Pharmaceutical Co., Ltd.	Condensed heteroaryl derivatives
US7112594B2 (en)	2000-08-09	2006-09-26	Mitsubishi Pharma Corporation	Fused bicyclic amide compounds and medicinal use thereof
WO2003082847A1 (en) *	2002-03-28	2003-10-09	Tanabe Seiyaku Co., Ltd.	Benzofuran derivative
AU2003257145B2 (en) *	2002-08-02	2008-11-13	Merck Sharp & Dohme Corp.	Substituted furo (2,3-b) pyridine derivatives
AU2004283751B2 (en) *	2003-10-24	2011-05-19	Exelixis, Inc.	p70S6 kinase modulators and method of use

2003
- 2003-09-26 JP JP2003334598A patent/JP2005104838A/ja active Pending
- 2003-12-31 TW TW092137593A patent/TWI328588B/zh not_active IP Right Cessation
2004
- 2004-01-08 WO PCT/JP2004/000074 patent/WO2004063202A1/ja not_active Ceased
- 2004-01-08 CA CA2510519A patent/CA2510519C/en not_active Expired - Fee Related
- 2004-01-08 JP JP2005507978A patent/JP4310437B2/ja not_active Expired - Fee Related
- 2004-01-08 MX MXPA05007408A patent/MXPA05007408A/es active IP Right Grant
- 2004-01-08 NZ NZ541198A patent/NZ541198A/en not_active IP Right Cessation
- 2004-01-08 KR KR1020077017495A patent/KR20070094818A/ko not_active Withdrawn
- 2004-01-08 MY MYPI20040049A patent/MY139461A/en unknown
- 2004-01-08 AU AU2004204003A patent/AU2004204003B2/en not_active Ceased
- 2004-01-08 KR KR1020057012844A patent/KR100827263B1/ko not_active Expired - Fee Related
- 2004-01-08 RU RU2005125204/04A patent/RU2302422C2/ru not_active IP Right Cessation
- 2004-01-08 BR BR0406721-5A patent/BRPI0406721A/pt not_active IP Right Cessation
- 2004-01-08 US US10/540,878 patent/US7514449B2/en not_active Expired - Fee Related
- 2004-01-08 CN CNB2004800019411A patent/CN100344632C/zh not_active Expired - Fee Related
- 2004-01-08 PL PL378249A patent/PL378249A1/pl not_active Application Discontinuation
- 2004-01-08 EP EP04700778A patent/EP1582521A4/en not_active Withdrawn
- 2004-01-09 AR ARP040100056A patent/AR042827A1/es unknown
2005
- 2005-06-15 IL IL169193A patent/IL169193A0/en unknown
- 2005-06-20 ZA ZA200504972A patent/ZA200504972B/en unknown
- 2005-08-08 NO NO20053762A patent/NO20053762L/no not_active Application Discontinuation
2009
- 2009-01-29 US US12/320,583 patent/US7737161B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2004063202A1 (ja)	2004-07-29
JP4310437B2 (ja)	2009-08-12
CA2510519C (en)	2010-03-16
US20090156803A1 (en)	2009-06-18
AU2004204003B2 (en)	2007-03-29
MY139461A (en)	2009-10-30
TWI328588B (en)	2010-08-11
IL169193A0 (en)	2007-07-04
EP1582521A4 (en)	2007-09-19
US7737161B2 (en)	2010-06-15
NO20053762D0 (no)	2005-08-08
PL378249A1 (pl)	2006-03-20
AU2004204003A1 (en)	2004-07-29
NZ541198A (en)	2008-01-31
AR042827A1 (es)	2005-07-06
RU2005125204A (ru)	2006-01-27
US20060094724A1 (en)	2006-05-04
KR100827263B1 (ko)	2008-05-07
BRPI0406721A (pt)	2005-12-20
JPWO2004063202A1 (ja)	2006-05-18
RU2302422C2 (ru)	2007-07-10
CA2510519A1 (en)	2004-07-29
CN100344632C (zh)	2007-10-24
KR20070094818A (ko)	2007-09-21
TW200413385A (en)	2004-08-01
ZA200504972B (en)	2006-04-26
EP1582521A1 (en)	2005-10-05
CN1723210A (zh)	2006-01-18
JP2005104838A (ja)	2005-04-21
US7514449B2 (en)	2009-04-07
KR20050091081A (ko)	2005-09-14
MXPA05007408A (es)	2005-09-12

Publication	Publication Date	Title
NO20053762L (no)	2005-10-07	Kondensert furanforbindelse.
NO20072605L (no)	2007-09-05	Nytt antranilinsyrederivat eller et salt derav
NO20060220L (no)	2006-05-02	Forbindelser med inhiberene aktivitet mot natriumavhengige transportorer
DE60221098D1 (de)	2007-08-23	Kondensierte heterocyclische derivate
EA200601235A1 (ru)	2006-12-29	Производные тиазола
EP1637521A4 (en)	2009-08-26	NEW TRICYCLIC HETEROCYCLIC COMPOUND
NO20082389L (no)	2008-08-18	2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler
NO20076006L (no)	2007-11-21	Acetylenderivater
NO20060706L (no)	2006-02-14	Inhibitorer av serinproteaser, spesielt HCV NS3-NS4A-protease
EP1669352A4 (en)	2008-12-17	THIAZOLINE DERIVATIVE AND ITS USE
EP1564213A4 (en)	2009-05-27	IMIDAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION AND USE THEREOF
DK0976748T3 (da)	2004-03-22	Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
NO20082077L (no)	2008-06-04	Spirosykliske quinazolinderivater som PDE7-inhibitorer
ATE337318T1 (de)	2006-09-15	Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
EA200500095A1 (ru)	2005-06-30	Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств
DE60329189D1 (de)	2009-10-22	Pyrrolidinderivate als oxytocin antagonisten
NO20061831L (no)	2006-04-25	Benzofuranderivater av karbamoyltype
NO20063111L (no)	2006-09-05	Fremgangsmate for fremstilling av tiazolpyrimidiner
EP1254907A4 (en)	2004-11-24	Pyrrolopyridazine CONNECTIONS
TW200616679A (en)	2006-06-01	Modified-release preparation
DK1589023T3 (da)	2010-12-13	Oligosaccharid-derivat
NO20062307L (no)	2006-07-19	Spirofuropyridinarylderivater
MY151167A (en)	2014-04-30	Benzimidazole compound
MX2008002753A (es)	2008-04-07	Derivados de piridazinona utilizados para el tratamiento de dolor.
NO20054020L (no)	2005-10-27	Medisin for forhindring og behandling av arterosklerose og hypertensjon

Legal Events

Date	Code	Title	Description
2012-08-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application